$5B+
assets under management
2020
core, open-end fund established
250%
fund growth since inception
Information as of December 31, 2023.
VENTAS INVESTMENT MANAGEMENT
Ventas Investment Management (VIM) leverages the full power of Ventas to provide institutional investors with the opportunity to co-invest directly in healthcare real estate, capitalizing on Ventas’s position as a trusted industry expert with a proven track record of success through market cycles.
With over $39 billion in strategic investments and ~18% annualized total return to its public shareholders since the beginning of 2000, Ventas is a natural partner for institutional private capital investors seeking to capitalize on the opportunity provided by demographically driven real estate.
The VIM Platform has over $5B in assets under management and consists of the core, open-end Ventas Life Science & Healthcare Real Estate Fund, our life science development joint venture with GIC and our senior housing development joint venture with a state pension plan.
PARTNERING WITH VENTAS
SECTOR SPECIALIZATION
Ventas is a leading owner of real estate serving the needs of the large and growing aging population. We have unmatched sector expertise in our demographically driven asset classes, strong relationships throughout the healthcare industry and insights from ~1,400 properties fueling our proprietary data analytics platform. These competitive advantages power powering consistent, superior returns.
SCALE & DIVERSIFICATION
With an enterprise value of over $30 billion, we utilize scale, best-in-class processes and our team’s proprietary knowledge and relationships, honed across our portfolio of ~1,400 properties, to enhance investment selection and returns. Our deep understanding of each asset class informs and enhances our success across the healthcare spectrum.
ONE VENTAS, ONE TEAM
VIM investors benefit from the proven, long-tenured interdisciplinary Ventas team of over 200 professionals, including our engaged executive management, supported by state-of-the-art resources and best-in-class proprietary analytics. With Ventas co-investments between 20% and 50%, our shareholders directly benefit from our private capital investments.
UNMATCHED EXPERTISE, STRONG PARTNERSHIPS
The ability to underwrite, create and maintain long-term partnerships with leading life science companies, research universities, health systems, care providers and specialty developers is essential in healthcare real estate. No one does this better than Ventas. Our existing relationships and deep knowledge base provide a competitive advantage that creates investment opportunities and helps drive operating performance.
HIGHLY FRAGMENTED $1 TRILLION MARKET WITH POWERFUL DEMOGRAPHICS
The growing, highly fragmented trillion-dollar healthcare real estate market is ripe for continued consolidation and additional investment. The growth in the market is supported by unprecedented growth in the aging population and scientific breakthroughs such as cell and gene therapies.
ESG LEADERSHIP
Ventas is widely recognized for commitment to and implementation of smart environmental, social and governance (ESG) policies that are essential to delivering long-term superior results. Learn more about Ventas’s ESG strategy.
PLATFORM VENTURES
Ventas Life Science and Healthcare Real Estate Fund, L.P: Ventas Life Science and Healthcare Real Estate Fund, L.P. is an open-end fund focused on core and core plus life science facilities, outpatient medical buildings and senior housing communities in the United States. As of December 31, 2023, the Fund had approximately $2.7 billion in assets under management. Ventas is the Fund Sponsor and General Partner of the Fund, as well as a 20% co-investor.
GIC Research & Innovation Development Joint Venture: In October 2020, Ventas formed a joint venture with GIC, a leading global investment firm established to manage Singapore’s foreign reserves. The joint venture, of which Ventas is the managing member, initially owned four university-based research and innovation development projects with total estimated project costs of approximately $930 million. The joint venture has been expanded to over $1.85 billion in assets through additional life science development projects. Ventas is a 53% co-investor.
State Pension Fund Joint Venture: Principally focused on ground up development and value-added redevelopment of senior housing communities with premier operators, this joint venture recently opened 9 state-of-the-art Class A senior housing communities in major metropolitan markets. Ventas serves as the managing member of the joint venture and is a 25% co-investor.